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 25 
SUMMARY 26 
Background 27 
Patients with metastatic spinal tumours have a limited prognosis. Surgical complications which may 28 
result in prolonged hospitalisation or readmission are highly undesirable.  Surgical site infection (SSI) 29 
is one such complication which can, in extreme cases, lead to death. 30 
Aim 31 
To assess the impact of SSI on patient survival after surgery for spinal metastases. 32 
Methods 33 
Demographic, operative and survival data were collected on 152 patients undergoing surgery for 34 
spinal metastasis at a large UK tertiary referral centre. American Society of Anesthesiologists (ASA) 35 
grade and the Revised Tokuhashi Score (RTS) were determined as measures of health status and 36 
prognosis, respectively, at baseline. A semi-parametric Cox proportional hazards survival analysis 37 
was used to assess the relationships between covariates and survival. 38 
Findings 39 
Seventeen patients (11.2%) experienced SSI. Overall, median survival time from operation was 262 40 
days (95% CI: 190-334 days) and 12 month survival was 42.1%. RTS (p<0.001; hazard ratio 0.82; 95% 41 
confidence interval: 0.76-0.89) and ASA grade (p=0.028; hazard ratio 1.37; 95% confidence interval: 42 
1.03-1.82) were significantly associated with survival, with better survival found in patients with 43 
higher RTS and lower ASA scores. Infection status was of substantive importance, with better 44 
survival in those without SSI (p=0.075).   45 
Conclusion 46 
Twelve month survival in patients undergoing surgery for spinal metastasis is approximately 42%. 47 
RTS and ASA scores can be used as indicators of patient survival either in combination or 48 
individually. While SSI has some negative impact on survival, a larger study sample would be needed 49 
to confirm whether this is statistically significant. 50 
Key Words 51 
Metastasis; Spine; Surgical site infection; Survival. 52 
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 54 
INTRODUCTION 55 
Surgical intervention for patients with metastatic spinal tumours is indicated in patients with pain, 56 
instability, or neurological compromise who have a life expectancy exceeding 3 months, according to 57 
the National Institute of Health and Care Excellence (NICE) Clinical Guideline 751.  Surgery aims to 58 
prevent or relieve pain, and symptoms associated with mechanical instability and neurological 59 
compromise 2, 3. Complications which jeopardise the success of the operation are therefore highly 60 
undesirable.  Surgical site infection (SSI) is one such complication, being the third most commonly 61 
occurring healthcare-associated infection (HAI) in England (accounting for approximately 16%). SSI 62 
has a significant impact on the management of patients undergoing spinal surgery, the length of 63 
time they spend in hospital, and how much money is spent on additional treatment 4. 64 
Although there is little evidence available to demonstrate a direct link between SSI and mortality 65 
specifically in spinal tumour patients, it has been suggested that those suffering SSI as a result of 66 
several types of procedure are overall twice as likely to die and 60% more likely to spend time in the 67 
intensive care unit 5.  Determining the risk of SSI and its potential impact on mortality in patients 68 
undergoing specialist surgical treatment will further highlight the importance of this complication 69 
and the need to implement preventative measures.  70 
A significant proportion of patients presenting with spinal metastases are unaware that they have a 71 
primary tumour, with symptoms of spinal cord compression being the first indication of the disease.  72 
Others, however, are known to be suffering from cancer and receiving treatment.  Baseline health 73 
status for those undergoing surgery can vary substantially between patients.  The Revised Tokuhashi 74 
Score (RTS) is a published system recommended by NICE as a tool to determine eligibility for surgery, 75 
as it is a recognised as being able to accurately predict survival 6.  However, some healthcare 76 
providers do not use the RTS to strictly determine which patients should be offered an operation 77 
because not all have a bone scan or a staging computed tomography (CT) pre-operatively, and 78 
because of the perceived palliative benefits of surgery even in those who might have a life 79 
expectancy less than three months. Generally, the RTS suggests that those with a score of 8 or less 80 
have a predicted survival of up to 6 months, meaning that conservative or palliative treatments are 81 
indicated.  Those with scores of 12 to 15 have a predicted survival of more than 12 months, meaning 82 
that excisional surgery may be appropriate.  Those with a RTS from 9 to 11 are more often suitable 83 
for palliative surgery rather than excisional surgery.  Given that RTS appears to be useful in 84 
predicting outcomes for patients with spinal metastasis, this score could be used to standardise 85 
patients at baseline (i.e. the time of their operation) when investigating whether there is an 86 
association between SSI and mortality.  Similarly, the American Society of Anesthesiologists (ASA) 87 
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grade is a recognised scoring system which can be used to determine patient fitness for surgery 7.  88 
ASA grade is relatively more simple than the RTS to determine, and is routinely recorded prior to 89 
surgery in the majority of cases.  Its use is also recommended by NICE in determining the 90 
appropriateness of surgery for patients with spinal tumours. 91 
Therefore, the aim of this study was to assess the impact of SSI on patient survival following surgery 92 
for spinal metastatic tumours, after controlling for baseline fitness using both RTS and ASA grades. 93 
 94 
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METHODS 96 
This was a sub-study of an ethically approved case note review of all adult patients (aged ≥18 years) 97 
who had undergone surgical treatment for spinal metastatic tumours at Salford Royal NHS 98 
Foundation Trust (SRFT) between 1st January 2009 and 31st December 2012 8.  Demographic (age, 99 
sex), operative (date of operation, type of procedure, presence or absence of SSI) and survival data 100 
(date of death, if applicable) were collected.  Final follow up assessment was conducted on 15th July 101 
2014.  In addition, the RTS was determined retrospectively using available medical records and ASA 102 
grade was obtained from the surgical documentation. RTS and ASA were determined to give an 103 
indication of health status at baseline (i.e. the time of surgery). 104 
Definition of SSI 105 
The presence or absence of a SSI (superficial or deep) was defined using the criteria set out by Public 106 
Health England 9, which is largely based on the definitions published by the Centers for Disease 107 
Control and Prevention (CDC) and the work of Horan et al. 10.  SSIs were classified by the SSI 108 
surveillance nurse for the neurosurgery department, as per standard routine for the reporting of SSIs 109 
through the hospital SSI Surveillance Service. 110 
Data Collection 111 
Data were collected from existing patient case notes and associated medical records (e.g. medical 112 
images) and were anonymised prior to analysis; no contact with patients or relatives was required 113 
for additional data collection.  RTS was calculated based on relevant clinically available data; ideally, 114 
RTS would be determined pre-operatively in order that this score can be used to assist in assessing 115 
patients’ suitability for surgery.  However, RTS is not formally recorded routinely at our institution 116 
and so this score was determined retrospectively based on the method described by Tokuhashi et al. 117 
6 where possible, with the exception of instances where the number of extra-spinal bony metastases 118 
was unavailable from bone scintigraphy or magnetic resonance imaging (MRI).  In these cases, 119 
staging CT was used.  ASA grade was recorded directly from the surgical pathway documentation.  120 
All patients were followed up at at least one year post-surgery. Data relating to infection status and 121 
survival were collected at this time point. 122 
Statistical Analysis 123 
Overall survival was assessed using the Kaplan-Meier method. A semi-parametric Cox proportional 124 
hazards survival (time-to-event) analysis was undertaken to assess the relationships between 125 
covariates and survival. 126 
127 
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RESULTS 128 
A total of 152 patients (77 females and 75 males) underwent surgery for spinal metastasis over the 129 
four year study period.  Mean age at operation was 60.5 years (SD 12.9 years). Seventeen patients 130 
(11.2%) experienced SSI (14 superficial and 3 deep). At the time of last follow up, 117 patients had 131 
died. Median survival time from operation for the whole cohort was 262 days (95% CI: 190-334 132 
days).  This equates to 42.1% at 12 months, and 19.6% at five years.  Median survival time for 133 
patients experiencing SSI was 135 days (95% CI: 62-208 days), and for those without infection, 276 134 
days (95% CI: 183-369 days).   135 
The assumption of proportional hazards was found to be tenable, and measures of patient fitness 136 
were not excessively correlated. The Cox analysis found both RTS and ASA score to be significantly 137 
associated with survival (Table 1), with better survival found in patients with higher RTS and lower 138 
ASA scores. 139 
Direction of approach was not considered as a candidate factor due to only one patient with an SSI 140 
experiencing an anterior approach, and less than 10% of patients in total experiencing an anterior 141 
approach. Hence direction of approach does not adequately distinguish between either cases, or 142 
between controls and was thus unsuitable as a candidate variable.  All cases (infection and non-143 
infection) were instrumented and so this too was not included in the analysis. 144 
  145 
[INSERT TABLE 1] 146 
 147 
Survival curves for RTS and ASA are shown in Figures 1 and 2.  Each additional point on the RTS scale 148 
was associated with an 18% lowered hazard of death (p<0.001).  Each additional point on the ASA 149 
scale is associated with a 37% raised hazard of death (p=0.028). 150 
 151 
[INSERT FIGURES 1 AND 2] 152 
 153 
Infection status was found to be of substantive importance, with better survival shown by those 154 
without SSI (p=0.075) (Figure 3).  Age at the time of surgery was not substantively related to survival 155 
(p=0.299).  156 
 157 
[INSERT FIGURE 3] 158 
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DISCUSSION 160 
The results of this study suggest that the median length of survival from the date of surgery for 161 
spinal metastases is approximately 8.6 months.  This is comparable to figures previously reported in 162 
the literature 11, 12.  Twelve month survival in the present cohort was 42.1% overall (29.4% in those 163 
with SSI and 43.7%in those without SSI. 164 
As expected, both ASA grade and RTS predicted survival effectively in patients in this study.  When 165 
using these scores to control for baseline health status, patients experiencing SSI survived on 166 
average half as long as those without SSI (though the association between infection and survival was 167 
substantive).  The low number of cases represented in this study may be a limiting factor and a 168 
reason why this association was not observed to be significant.  Nevertheless, this study describes 169 
the contemporary SSI rate in this patient group at a large UK specialist spinal centre, and is one of 170 
the first to demonstrate a relationship between SSI and mortality in this type of patient. 171 
It has been estimated that between 38 and 75% of deaths in patients with SSI are attributable to 172 
infection itself 13, 14, with SSI being an independent predictor of mortality.  Other studies have 173 
suggested that the type of surgery, and whether SSIs are deep/organ space have some bearing on 174 
the level of contribution of infection towards death 15.  While this seems logical, it is impossible in 175 
this study to indicate whether the type of infection (superficial or deep) had any effect on survival, 176 
given that only three cases were documented as being deep.  A larger case series would be needed 177 
to determine whether additional factors such as this played an important role in affecting survival 178 
outcome. 179 
It is suggested that there are approximately 4,000 cases of metastatic spinal cord compression 180 
diagnosed each year in England and Wales 1, though this is likely to be an underestimate.  Surgery is 181 
generally undertaken as a palliative measure to relieve pain and stabilise the spine to prevent 182 
further neurological damage.  Estimating that only around 20% of these will undergo surgery 183 
(Richards, personal communication), and based on the 11.2% infection rate demonstrated in this 184 
study, 90 patients per year could be at risk of developing SSI. Given the differential in life expectancy 185 
demonstrated in this study between patients with and without SSI (141 days shorter in SSI patients), 186 
theoretically, this equates to approximately 12,600 days (34.5 years) of life lost which relates to the 187 
onset of SSI for just those treated surgically over the period of one year.  This, coupled with the 188 
distressing consequences of infection (prolonged in-patient hospitalisation, isolation away from 189 
home, additional treatments) and the inevitable economic costs associated with SSI 4, can be 190 
exceedingly frustrating for a service under pressure to provide better care at a lower cost.  191 
Scrupulous peri-operative practice and the standardisation of effective processes in the operating 192 
theatre may go some way to improving outcomes in terms of SSI rates 16-18.  In addition, effective 193 
8 
surgical work-up and the notion of ‘prehabilitation’ in the pre-operative period may better prepare 194 
some elective spinal surgery patients physiologically to improve some outcomes 19. However, there 195 
is little evidence to support this approach in reducing post-operative complication rate.  196 
Furthermore, in urgent cases – such as those needing surgery for spinal tumours – this window of 197 
opportunity is generally not available to the care team, meaning that extra preventative measures 198 
are highly desirable and clearly warranted.  This is especially so in cancer patients given that they are 199 
at increased risk of SSI, due largely to their immunosuppressed state 20, 21. 200 
The results provided by this study may be useful during the consenting process for spinal surgery.  201 
The appropriateness and quality of information patients receive prior to their operation, about the 202 
procedure and its associated risks are of utmost importance when ensuring their decisions are fully 203 
informed and their expectations managed.  Thus, patients have a right to know about the 204 
implications of SSI.  Despite this, it is evident from previous studies that many patients are poorly 205 
informed about SSIs; some are unable to recognise the signs and symptoms of an infection or 206 
unaware of the causes or the risk factors of SSI 22.  This low level of awareness about SSI, coupled 207 
with the potential for such devastating effects on quality of life and clinical outcome indicates that 208 
greater attention should be paid to this complication across the board.  Statistics relating to 209 
individual departments, such as those presented in this study, could go some way to educating both 210 
staff and patients of the institution, in an effort to emphasise risk factors for SSI, what can be done 211 
to combat them, and the importance of their consequences.  It is hoped this would then translate 212 
into the adoption of processes – on the part of both patient and care team – which drive down the 213 
incidence of SSI. 214 
 215 
CONCLUSIONS 216 
One-year survival in patients undergoing surgery for spinal metastases is approximately 42%. Either 217 
or both of RTS or ASA scores can be used as reliable indicators of survival in these patients. While SSI 218 
has some negative impact on survival, a larger study sample would be needed to confirm that this is 219 
a statistically significant association.  The evidence provided by this study may raise awareness of the 220 
importance of SSI as a complication of surgery for spinal metastasis. 221 
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